TITLE

Significance of Pseudomonas aeruginosa in sputum

AUTHOR(S)
Cargill, J S
PUB. DATE
September 1973
SOURCE
British Medical Journal;9/15/1973, Vol. 3 Issue 5880, p594
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64108269

 

Related Articles

  • Loss of Microbicidal Activity and Increased Formation of Biofilm Due to Decreased Lactoferrin Activity in Patients with Cystic Fibrosis. Rogan, Mark P.; Taggart, Clifford C.; Greene, Catherine M.; Murphy, Philip G.; O'Neill, Shane J.; McElvaney, Noel G. // Journal of Infectious Diseases;10/1/2004, Vol. 190 Issue 7, p1245 

    Intractable formation of bio film by and infection with the opportunistic pathogen Pseudomonas aeruginosa are hallmarks of cystic fibrosis (CF). Lactoferrin, an innate immunity protein, has recently been shown to inhibit the formation of P. aeruginosa biofilm. Partial cleavage of lactoferrin by...

  • Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. Iain Lamont; Anna Konings; David Reid // BioMetals;Feb2009, Vol. 22 Issue 1, p53 

    Abstract  The bacterium Pseudomonas aeruginosa is commonly isolated from the general environment and also infects the lungs of patients with cystic fibrosis (CF). Iron in mammals is not freely available to infecting pathogens although significant amounts of extracellular iron are available...

  • Comparison of Microbiomes from Different Niches of Upper and Lower Airways in Children and Adolescents with Cystic Fibrosis. Boutin, Sébastien; Graeber, Simon Y.; Weitnauer, Michael; Panitz, Jessica; Stahl, Mirjam; Clausznitzer, Diana; Kaderali, Lars; Einarsson, Gisli; Tunney, Michael M.; Elborn, J. Stuart; Mall, Marcus A.; Dalpke, Alexander H. // PLoS ONE;Jan2015, Vol. 10 Issue 1, p1 

    Changes in the airway microbiome may be important in the pathophysiology of chronic lung disease in patients with cystic fibrosis. However, little is known about the microbiome in early cystic fibrosis lung disease and the relationship between the microbiomes from different niches in the upper...

  • Susceptibility Testing of Respiratory Isolates from Patients with Cystic Fibrosis (CF) Who Received Antibiotics in Combination and Treatment Outcome. Deresinski, Stan // Clinical Infectious Diseases;2/1/2006, Vol. 42 Issue 3, preceding p315 

    The article focuses on combination antibiotic susceptibility testing for patients infected with cystic fibrosis (CF). There was no evidence that multiple combination antibiotic testing susceptibility of gram-negative isolates from sputum samples from patients with CF to guide antibiotic therapy...

  • Fatigue in bronchiectasis. Hester, K.L.M.; Macfarlane, J.G.; Tedd, H.; Jary, H.; McAlinden, P.; Rostron, L.; Small, T.; Newton, J.L.; De Soyza, A. // QJM: An International Journal of Medicine;Mar2012, Vol. 105 Issue 3, p235 

    Background: Fatigue is a complex, disabling symptom in non-CF bronchiectasis (nCF-Br). Fatigue can be formally measured using the validated fatigue impact scale (FIS). The relationship between fatigue and clinically important factors such as airflow obstruction, breathlessness or Pseudomonas...

  • Immunotherapy of Pseudomonas Infections.  // Annals of Internal Medicine;Feb67, Vol. 66 Issue 2, p443 

    Editorial. Comments on the significance of immunotherapy in pseudomonas aeruginosa infections. Increase of pseudonomas infections; Effectivity of antibiotics; Steps toward immunotherapy.

  • P. AERUGINOSA INFECTION.  // Advocate;9/20/94, Issue 664, p25 

    Reports on the findings of Mount Sinai School of Medicine researchers that Pseudomonas aeruginosa bacteremia is a significant opportunistic pathogen in patients with AIDS.

  • Phenotypic diversity within a Pseudomonas aeruginosa population infecting an adult with cystic fibrosis. Clark, Shawn T.; Diaz Caballero, Julio; Cheang, Mary; Coburn, Bryan; Wang, Pauline W.; Donaldson, Sylva L.; Zhang, Yu; Liu, Mingyao; Keshavjee, Shaf; Yau, Yvonne C.W.; Waters, Valerie J.; Elizabeth Tullis, D.; Guttman, David S.; Hwang, David M. // Scientific Reports;6/5/2015, p10932 

    Chronic airway infections caused by Pseudomonas aeruginosa contribute to the progression of pulmonary disease in individuals with cystic fibrosis (CF). In the setting of CF, within-patient adaptation of a P. aeruginosa strain generates phenotypic diversity that can complicate microbiological...

  • Is the Improvement of CF Patients, Hospitalized for Pulmonary Exacerbation, Correlated to a Decrease in Bacterial Load? Deschaght, Pieter; Schelstraete, Petra; Van Simaey, Leen; Vanderkercken, Marleen; Raman, Ann; Mahieu, Linda; Van daele, Sabine; De Baets, Frans; Vaneechoutte, Mario // PLoS ONE;Nov2013, Vol. 8 Issue 11, p1 

    Background: Cystic Fibrosis (CF) patients are vulnerable to airway colonization with Pseudomonas aeruginosa. In case eradication fails after antibiotic treatment, patients become chronically colonized with P. aeruginosa, with recurrent pulmonary exacerbation, for which patients typically are...

  • Prevalence and Antimicrobial Susceptibility Pattern of Pseudomonas aeruginosa Isolated from Environmental and Clinical Samples in Upper Egypt. Afifi, Magdy M.; Suelam, I. I. A.; Soliman, M. T. A.; El-Gohary, M. G. S. // International Journal of Biological Chemistry;2013, Vol. 7 Issue 2, p47 

    The present study was performed to isolate, characterize and evaluate the prevalence of Pseudomonas aeruginosa (P. aeruginosa) in 600 samples (environmental and clinical) at Upper Egypt. Antibiotic sensitivity, biotyping and molecular identification of P. aeruginosa isolates were determined, as...

Share

Read the Article

Other Topics